Combinatorial chemistry in cancer research

Area of Science:

• Oncology
• Medicinal Chemistry
• Drug Discovery

Background:

• Chemotherapy remains a cornerstone of cancer treatment, driving demand for more effective and selective anticancer drugs.
• Combined therapeutic strategies require novel agents with enhanced efficacy and targeting capabilities.
• Advancements in molecular and cellular biology facilitate the development of high-throughput in vitro assays for drug screening.

Purpose of the Study:

• To review the impact of combinatorial chemistry on the discovery of anticancer drugs.
• To highlight the role of combinatorial chemistry in developing agents for cancer treatment.
• To discuss anticancer drugs discovered through combinatorial chemistry that are in clinical trials or on the market.

Main Methods:

• Utilizing combinatorial chemistry to rapidly synthesize large collections of compounds (chemical libraries).
• Employing automated in vitro assays for high-throughput screening of synthesized compounds.
• Analyzing the contribution of these methods to the drug discovery pipeline for cancer.

Main Results:

• Combinatorial chemistry has significantly impacted drug discovery programs targeting cancer.
• This technology enables the efficient and rapid preparation of diverse chemical libraries.
• Numerous anticancer compounds identified through this approach are progressing through clinical trials or are already marketed.

Conclusions:

• Combinatorial chemistry is a pivotal technology in modern anticancer drug discovery.
• Its application has accelerated the identification and development of novel chemotherapy agents.
• The impact of combinatorial chemistry is evident in the current pipeline and market of cancer therapeutics.